These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36046499)

  • 1. Preferences for Patients with Type 2 Diabetes Mellitus for Medications in Shandong Province, China: A Discrete Choice Experiment.
    Lv Y; Ren R; Tang C; Song K; Li S; Wang H
    Patient Prefer Adherence; 2022; 16():2335-2344. PubMed ID: 36046499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
    Huang Y; Huang Q; Xu A; Lu M; Xi X
    Front Public Health; 2021; 9():782964. PubMed ID: 35178370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
    Mansfield C; Sikirica MV; Pugh A; Poulos CM; Unmuessig V; Morano R; Martin AA
    Diabetes Ther; 2017 Dec; 8(6):1365-1378. PubMed ID: 29101681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.
    Mühlbacher A; Bethge S
    Eur J Health Econ; 2016 Dec; 17(9):1125-1140. PubMed ID: 26682548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
    Chuang LH; Zhang H; Hong T; Xie S
    Patient; 2024 Sep; 17(5):565-574. PubMed ID: 38642244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences of patients with diabetes mellitus for primary healthcare institutions: a discrete choice experiment in China.
    Lv Y; Qin J; Feng X; Li S; Tang C; Wang H
    BMJ Open; 2023 Jun; 13(6):e072495. PubMed ID: 37369417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK.
    Gelhorn HL; Stringer SM; Brooks A; Thompson C; Monz BU; Boye KS; Hach T; Lund SS; Palencia R
    Diabetes Obes Metab; 2013 Sep; 15(9):802-9. PubMed ID: 23464623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment.
    Mühlbacher AC; Sadler A; Juhnke C
    Eur J Health Econ; 2021 Apr; 22(3):425-443. PubMed ID: 33587221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experiment.
    Panchal R; Nguyen D; Ghule P; Li N; Giannouchos T; Pan RJ; Biskupiak J; Britton L; Nohavec R; Slager S; Ngorsuraches S; Brixner D
    J Manag Care Spec Pharm; 2023 Feb; 29(2):139-150. PubMed ID: 36705280
    [No Abstract]   [Full Text] [Related]  

  • 10. Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
    Fifer S; Rose J; Hamrosi KK; Swain D
    BMC Health Serv Res; 2018 Aug; 18(1):675. PubMed ID: 30165844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese patients' preference for pharmaceutical treatments of osteoporosis: a discrete choice experiment.
    Si L; Tu L; Xie Y; Palmer AJ; Gu Y; Zheng X; Li J; Lv Q; Qi J; Lin Z; Chen M; Gu J; Hiligsmann M
    Arch Osteoporos; 2019 Jul; 14(1):85. PubMed ID: 31367860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A discrete choice experiment evaluation of patients' preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management.
    Guimarães C; Marra CA; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
    Patient Prefer Adherence; 2010 Dec; 4():433-40. PubMed ID: 21301591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment.
    Morillas C; Feliciano R; Catalina PF; Ponte C; Botella M; Rodrigues J; Esmatjes E; Lafita J; Lizán L; Llorente I; Morales C; Navarro-Pérez J; Orozco-Beltran D; Paz S; Ramirez de Arellano A; Cardoso C; Tribaldos Causadias M
    Patient Prefer Adherence; 2015; 9():1443-58. PubMed ID: 26508841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes.
    Hauber AB; Han S; Yang JC; Gantz I; Tunceli K; Gonzalez JM; Brodovicz K; Alexander CM; Davies M; Iglay K; Zhang Q; Radican L
    Patient Prefer Adherence; 2013; 7():937-49. PubMed ID: 24086104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating patients' preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China.
    Geng J; Bao H; Feng Z; Meng J; Yu X; Yu H
    BMC Public Health; 2022 Oct; 22(1):1860. PubMed ID: 36199056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment.
    Donnan JR; Johnston K; Chibrikov E; Marra CA; Aubrey-Bassler K; Najafzadeh M; Nguyen H; Gamble JM
    Can J Diabetes; 2020 Feb; 44(1):6-13. PubMed ID: 31311729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey.
    Liu S; Liu J; Si L; Ke X; Liu L; Ren Y; Bao S; Li F; Yu Y; Pan Q; Wei Y; Chen Y
    BMJ Glob Health; 2023 Apr; 8(4):. PubMed ID: 37041021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eliciting Depression Patients' Preferences for Medication Management: A Protocol for Discrete Choice Experiment.
    Xie P; Li HQ; Peng WL; Yang H
    Patient Prefer Adherence; 2024; 18():289-300. PubMed ID: 38327728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' preferences for health insurance coverage of new technologies for treating chronic diseases in China: a discrete choice experiment.
    Geng J; Chen X; Bao H; Qian D; Shao Y; Yu H
    BMJ Open; 2020 Sep; 10(9):e038051. PubMed ID: 32967882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK.
    Gelhorn HL; Poon JL; Davies EW; Paczkowski R; Curtis SE; Boye KS
    Patient Prefer Adherence; 2015; 9():1611-22. PubMed ID: 26635470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.